Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Company
Haihu Pharma adopts synthetic method to produce Ephedrine2010-10-15
Tylosin capacity of Duowei will reach 5000 ton in this year2010-10-13
Wante Pharma invest 1 bln Yuan to build APIs project2010-10-11
One APIs company to locate in Wannian county2010-10-11
PPD inaugurates new office in Beijing2010-10-09
Shengxue Dacheng got CEP certificate of Oxytetracycline Hcl2010-10-09
Shandong Tianli began to supply Vitamin C2010-09-28
Ruiying Pharma got cGMP certification from FDA2010-09-27
Northeast Pharma stops some production lines of Vit. C for 45 days2010-09-27
RHEI Pharma newly signed $30 mn supplying pact2010-09-26
Yurun started the building of Heparin Sodium project2010-09-26
Taizhou Hisound resumes production of feed grade Vitamin D32010-09-20
Starlake's Threonine supply falls intense2010-09-20
Qingsong plans to produce Capecitabine, Decitabine etc.2010-09-19
DK Sinopharma sales up 28% in Q22010-09-16
STA got certification from ISO quality organization2010-09-15
Xinfu Pharma newly got 3 patent authorizations2010-09-14
Hepalink founds JV to produce Heparin formulations2010-09-14
NCPC's new cephalosporins facilities into production before Oct. 12010-09-13
Boehringer opened resarch center in Shanghai2010-09-10
Lukang's 7-ACA capacity increases2010-09-10
Guobang Pharma won good harvest in first half year2010-09-09
Daxin Pharma will conduct workshop upgrade2010-09-09
Hisun immunowuppressant got EU marketing approval2010-09-07
Eisai brings new antidiabetes drug to China2010-09-06
Zhejiang Garden raises money to stretch its Vitami D3 product line2010-09-02
United Laboratories raised price of 2 bulk drugs2010-09-01
Senary begins to produce intermediates of Pioglitazone and Glimepiride.2010-09-01
Wuyi MSG to expand capacities of Mycophenolic acid and Sisomicin2010-09-01
Sinopharm is building antibiotics base in Datong2010-08-31
Guangji Pharma will soon resume Riboflavin production2010-08-30
Tuoyang passed environmental acceptance check for Vitamin C2010-08-30
2619个 页次:68/8232个/页 首页 上一页 下一页 尾页 转到:
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch
④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463